2ϩ signals in neurons use specific temporal and spatial patterns to encode unambiguous information about crucial cellular functions. To understand the molecular basis for initiation and propagation of inositol 1,4,5-trisphosphate (InsP 3 )-mediated intracellular Ca 2ϩ signals, we correlated the subcellular distribution of components of the InsP 3 pathway with measurements of agonist-induced intracellular Ca 2ϩ transients in cultured rat hippocampal neurons and pheochromocytoma cells. We found specialized domains with high levels of phosphatidylinositol-4-phosphate kinase (PIPKI␥) and chromogranin B (CGB), proteins acting synergistically to increase InsP 3 receptor (InsP 3 R) activity and sensitivity. In contrast, Ca 2ϩ pumps in the plasma membrane (PMCA) and sarco-endoplasmic reticulum as well as buffers that antagonize the rise in intracellular Ca 2ϩ were distributed uniformly. By pharmacologically blocking phosphatidylinositol-4-kinase and PIPKI␥ or disrupting the CGB-InsP 3 R interaction by transfecting an interfering polypeptide fragment, we produced major changes in the initiation site and kinetics of the Ca 2ϩ signal. This study shows that a limited number of proteins can reassemble to form unique, spatially restricted signaling domains to generate distinctive signals in different regions of the same neuron. The finding that the subcellular location of initiation sites and protein microdomains was cell type specific will help to establish differences in spatiotemporal Ca 2ϩ signaling in different types of neurons.
Introduction
To control many diverse intracellular processes (Berridge, 1998) , neuronal Ca 2ϩ signals encode information via distinct spatiotemporal patterns. Transient rises in cytoplasmic Ca 2ϩ concentration ([Ca 2ϩ ] i ) are generally restricted to specific cell compartments such as the presynaptic terminal or postsynaptic spine, regulating neurotransmission and synaptic modulation (Zucker, 1989; Yuste et al., 1999) . It has recently been shown that release of Ca 2ϩ from internal stores can also spread within a neuron as regenerative waves (Nakamura et al., 1999; Kapur et al., 2001) . Little is known about the basic properties of internal Ca 2ϩ release, including the site of origin. Stimulation of muscarinic acetylcholine receptors (mAChRs) in neuronally derived cells gives rise to Ca 2ϩ signals initiating in the neurite (Johenning et al., 2002) . Similarly, in pyramidal neurons of the hippocampus and neocortex, Ca 2ϩ transients evoked by synaptic activation of metabotropic glutamate receptors (mGluRs) are initiated in the proximal apical dendrite (Pozzo-Miller et al., 1996; Yeckel et al., 1999; Kapur et al., 2001; Larkum et al., 2003) . In many neurons, the second messenger inositol 1,4,5-trisphosphate (InsP 3 ) is the main trigger for generating elevations in [Ca 2ϩ ] i emanating from Ca 2ϩ channels in the endoplasmic reticulum (ER) (Nakamura et al., 2000; Rizzuto, 2001; Johenning et al., 2002) . A key to understanding the spatiotemporal characteristics of Ca 2ϩ signals is thus likely to lie in the various components of the InsP 3 pathway.
InsP 3 is generated by phospholipase C (PLC)-mediated cleavage of a phosphoinositide lipid precursor into InsP 3 and diacylglycerol (DAG) (Fig. 1) . Phosphatidylinositol-4-kinase (PI4K) synthesizes phosphatidylinositol-4-phosphate (PIP) from phosphatidylinositol (PI). Two subtypes termed II and III, differing in their sensitivity to the PI3K inhibitor wortmannin (Downing et al., 1996) , have been described previously (Barylko et al., 2001) . PIP is metabolized by phosphatidylinositol-4-phosphate-5-kinase (PIPK) to produce phosphatidylinositol-4,5-bisphosphate (PIP 2 ), the immediate InsP 3 precursor. PIPKI␥ is the main isoform in neurons (Wenk et al., 2001 ). PIP 2 is concentrated in plasma membranes (Watt et al., 2002) and is in itself an important cellular effector (Czech, 2003) .
The superfamily of Ca 2ϩ release channels comprises three isoforms of the InsP 3 receptor (InsP 3 R) and the ryanodine receptor (RyR). Although the biophysical properties and distribution of the RyRs are similar, each InsP 3 R isoform is characterized by a different InsP 3 affinity (Patel et al., 1999) , Ca 2ϩ -dependent inactivation (Bezprozvanny et al., 1991; Hagar et al., 1998) , tissue distribution (Furuichi and Mikoshiba, 1995; Sharp et al., 1999) , and regulation by phosphorylation (Tang et al., 2003) and additional endogenous modulators. The ERresident high-capacity, low-affinity Ca 2ϩ storage proteins chromogranin A (CGA) and CGB were found in a variety of neuroendocrine cells and neurons of the peripheral and central nervous systems (Winkler and Fischer-Colbrie, 1992) and have recently gained importance as activators of the InsP 3 R (Thrower et al., 2002 (Thrower et al., , 2003 .
Despite our extensive knowledge about many components of the Ca 2ϩ signaling tool kit, it remains unclear how cells use the different elements to achieve spatially and temporally distinct Ca 2ϩ signals. Here, we use fluorescence immunocytochemistry to demonstrate differential targeting of proteins enhancing and inhibiting InsP 3 -mediated Ca 2ϩ signaling in cultured hippocampal neurons and neuron-like pheochromocytoma cells (PC12 cells) (Koizumi et al., 1999) . With Ca 2ϩ imaging techniques, we show that manipulation of regionally specific protein domains modifies the kinetics and temporal aspects of neuronal Ca 2ϩ signals.
Materials and Methods
Cell culture and hippocampal neuron preparation. Rat adrenal pheochromocytoma cells (PC12 cells) were purchased from American Type Culture Collection (Manassas, VA) and grown in high-glucose DMEM supplemented with 10% heat-inactivated horse serum, 5% heat-inactivated fetal calf serum, 25 U/ml penicillin, and 25 g/ml streptomycin (all from Invitrogen, Grand Island, NY) in poly-L-lysine-coated flasks (BD Biosciences, Bedford, MA). Cells were cultured in a water-saturated atmosphere at 37°C and 5% CO 2 . To induce differentiation, cells were diluted to 3 ϫ 10 4 ml Ϫ1 and plated onto collagen-I-coated coverslips (BD Biosciences) treated with 0.1% (w/v) poly-L-lysine (Peptide Institute, Osaka, Japan) to promote adhesion. Cells were differentiated with 100 ng/ml nerve growth factor (NGF) (Alomone Laboratories, Jerusalem, Israel) for 7 d. Cultures were fed three times per week.
Low-density cultures of dissociated rat hippocampal neurons were prepared using a modification of a protocol described previously (Brewer et al., 1993) . Hippocampi were dissected from Sprague Dawley rat embryos (embryonic days 18 -19), incubated for 15 min with 0.03% trypsin, and dissociated using a fire-polished Pasteur pipette. Hippocampal cells with glia were then plated at a density of 3-6 ϫ 10 3 cm Ϫ1 on coverslips (Warner Instruments, Hamden, CT) coated with 0.1% (w/v) poly-Llysine (Peptide Institute) in Neurobasal medium supplemented with 5% fetal calf serum, 0.5 mM glutamine, 2% B-27, 50 U/ml penicillin, 50 g/ml streptomycin (all from Invitrogen, Grand Island, NY), and 25 M glutamate (Sigma, St. Louis, MO). Four hours after plating, the medium was replaced with serum-free Neurobasal supplemented with 0.5 mM glutamine, 2% B-27, 50 U/ml penicillin, and 50 g/ml streptomycin. One-third of the medium was replaced weekly. Cultures were used 10 -20 d after plating.
Transfection of PC12 cells. The pShooter-pCMV/myc/ER plasmid (Invitrogen, Carlsbad, CA) containing the cDNA for the near N-terminal CGB peptide or a scrambled peptide and the pcDNA3.1 DsRed2-N1 construct (Clontech, Palo Alto, CA) used to verify transfection have been described previously (Choe et al., 2004) . Twenty to 30 hours after plating, cells were cotransfected with 0.5 g of pcDNA3.1 DsRed2-N1 cDNA and 1.5 g of pShooter-pCMV/myc/ER with either the CGB fragment or the scrambled peptide using 3.5 l of Lipofectamine 2000 (Invitrogen, Carlsbad, CA) per 35 mm well. Cells were then differentiated with NGF and used 6 -7 d after transfection.
To monitor intracellular PIP 2 , CFP-PLC␦1(PH) (the pleckstrin homology domain of PLC␦1 linked to cyan fluorescent protein) was generated and expressed into cells as described previously (Johenning et al., 2004) .
Antibodies and immunocytochemistry. Each InsP 3 R was detected using isoform-specific antibodies. Rabbit polyclonal InsP 3 R1 and InsP 3 R2 antibodies (1:100) were purchased from A.G. Scientific (San Diego, CA). A mouse monoclonal antibody was used to label the N-terminal region of the human InsP 3 R3 (1:100; BD Transduction Laboratories, Lexington, KY). Similarly, each RyR isoform was identified using isoform-specific antibodies, all kindly provided by Dr. Vincenzo Sorrentino (Universita degli di Siena, Siena, Italy): mouse monoclonal RyR1 (1:100) and RyR2 (1:100) and rabbit polyclonal RyR3 (1:200). Rabbit polyclonal PIPKI␥ antibody (1:500) was a kind gift from Dr. G. di Paolo (Yale University, New Haven, CT). The other antibodies used included rabbit polyclonal PI4K␤ (1:200; Upstate Biotechnology, Lake Placid, NY), rabbit polyclonal mGluR1 and mGluR5 (1:100; Chemicon, Temecula, CA), mouse monoclonal PLC␤1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA), goat polyclonal CGA (1:100; Santa Cruz Biotechnology), mouse monoclonal CGB (1:100; BD Transduction Laboratories), goat polyclonal PMCA1 (1:100; Santa Cruz Biotechnology), goat polyclonal SERCA2 (sarco-endoplasmic reticulum, 1:50; Santa Cruz Biotechnology), and mouse monoclonal parvalbumin (1:100; Chemicon). Primary antibodies were visualized with fluorochrome-coupled secondary antibodies. The secondary antibodies used were Alexa Fluor 488 and 568 coupled with goat anti-rabbit and goat anti-mouse IgG and Alexa Fluor 488 and 594 coupled with donkey anti-goat IgG (all from Molecular Probes, Eugene, OR). Nuclei were stained by incubating the cells with TOPRO-3 (monomeric cyanine nucleic acid stain) for 20 min (1:200 in PBS; Molecular Probes).
Cells were fixed with 4% (w/v) paraformaldehyde in PBS containing 4% (w/v) sucrose (PBSS), pH 7.4, for 20 min at room temperature and permeabilized with 0.1% (v/v) Triton X-100 for 5 min. Nonspecific binding sites were blocked by incubating the cells with PBSS containing 10% normal goat serum (NGS) and 1% bovine serum albumin for 45 min. For CGA, PMCA1, and SERCA2 detection, NGS was replaced by fetal calf serum. Cells were exposed to primary and secondary antibodies diluted in PBSS with 1% bovine serum albumin for at least 2 h and 1 h, respectively. Labeled cells were visualized on an LSM510 META inverted confocal microscope (Zeiss, Oberkochen, Germany) using 40ϫ, 0.8 numerical aperture (NA) and 63ϫ, 1.4 NA oil-immersion objectives. Averaging eight frames reduced noise. Fluorochromes were excited with an argon laser at 488 nm (Alexa 488) and a helium-neon laser at 543 nm (Alex 568 and 594) and 633 nm (TOPRO-3). The appropriate emission filters were used for fluorescence detection.
Live cell imaging of the ER and mitochondria. PC12 cells on coverslips Fluorescence was observed at 500 -540 nm with custom-built external detectors using a 63ϫ, 1.4 NA objective. Mitochondria were labeled with 200 M MitoTracker Green FM dye (Molecular Probes) in growth medium for 30 min at 37°C. An argon laser at 488 nm was used for excitation. Fluorescence was detected with appropriate emission filters. Cells were observed on a Zeiss LSM510 upright confocal microscope using a 40ϫ, 0.8 NA water-immersion objective.
Ca 2ϩ fluorescence imaging. PC12 cells grown on glass coverslips were loaded with 9 M fluo-4 AM in 20% Pluronic F-127 in DMSO (all from Molecular Probes) for 20 min at 37°C in extracellular solution containing (in mM) 124 NaCl, 2.5 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 D-glucose, 25 NaHCO 3 and 1.25 NaH 2 PO 4 . Before imaging, cells were allowed an additional 5 min in dye-free extracellular solution for deesterification of the dye. The coverslip was used as the bottom of an open superfusion chamber mounted onto the stage of a Zeiss LSM510 upright confocal microscope. Cells were perfused continuously with extracellular solution at 5 ml/min. Solution changes were accomplished rapidly by means of a valve attached to a fourchambered superfusion reservoir. Perfusion with the muscarinic receptor agonist carbachol started after the cells had reached a stable baseline. An argon laser at 488 nm was used for excitation, and the emission signal was detected with the appropriate emission filter. Cells were observed using a 40ϫ, 0.8 NA waterimmersion objective, and whole-cell images were recorded every 200 ms for ϳ4 min. Increases in [Ca 2ϩ ] i were expressed as the ratio of fluorescence intensity F of fluo-4 over baseline F 0 , calculated as the average of at least 10 frames before fluorescence increase, and corrected for background fluorescence
Experiments were performed at 21°C.
For fluorescence imaging in hippocampal neurons, whole-cell patch-recording pipettes (2-4 M⍀) were pulled from borosilicate glass and filled with (in mM) 106 K-gluconate, 10 HEPES, 6 NaCl, 6 MgCl 2 , 0.2 EGTA, 2 ATP (disodium salt), 0.4 GTP (monosodium salt), 20 phosphocreatine (dipotassium salt), and 50
Figure 2. Proteins activating and inhibiting InsP 3 -mediated Ca 2ϩ signaling are targeted to distinct compartments in NGFdifferentiated PC12 cells. The subcellular localization was determined by indirect immunofluorescence as described in Materials and Methods. Proteins with an enhancing effect on Ca 2ϩ signals are depicted in green (a), and proteins reducing Ca 2ϩ levels are shown in red (b). Nuclei are shown in blue. In a and b, the bottom panels show the quantification of the fluorescence intensity along a typical neurite (shown as the red neurite in a miniature cell), plotted as a function of the distance from proximal (left) to distal (right) sections of the cell. a, PIPKI␥ and CGB were highly concentrated in the growth cones and the branching points of the neurites (arrows), suggesting a potential mechanism for spatiotemporally distinct Ca 2ϩ signaling patterns. The same result was obtained for CGA. PIP 2 , as monitored by visualizing CFP-PH, was located predominately in the plasma membrane of the growth cones (arrows) and is shown in cyan. A more uniform distribution was found for PI4K␤ and PLC␤. The ER extended throughout the 4 cell, dominating in the soma and growth cones. b, In contrast, proteins decreasing [Ca 2ϩ ] i were either not distributed asymmetrically or predominated in the soma: immunoreactivity for PMCA1 and SERCA2 was detected to the same extent in the cell body and the growth cones. Localization of parvalbumin was mainly somatic with weaker staining in the neurites. Mitochondria were distributed essentially evenly. Scale bar, 20 m. U/ml phosphocreatine kinase. Cells were perfused continuously at 1 ml/min with artificial CSF (ACSF) containing (in mM) 130 NaCl, 3 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 5 D-glucose, pH adjusted to 7.5. Whole-cell patch-clamp recordings were made from the soma with an npi SEC-05LX amplifier (Adams and List Associates, Westbury, NY) in discontinuous voltage-clamp mode. The resting membrane potential was typically near Ϫ55 mV. Series resistance was between 10 and 20 M⍀. Neurons were stimulated with bathapplied ( S)-3,5-dihyroxyphenylglycine (DHPG) (50 M; Tocris, Bristol, UK) dissolved directly into ACSF. A concentration of 10 M 6,7-dinitroquinoxaline-2,3-dione (DNQX) (Tocris) to block non-NMDA receptors was always present in the bathing solution. To measure changes in [Ca 2ϩ ] i , bis-fura-2 (100 M; Molecular Probes) was included in the pipette solution and allowed to diffuse into the neuron for at least 5 min before optical recordings began. Fluorescence images were recorded at 10 Hz with 380 nm excitation using a cooled charge-coupled device camera (Quantix 57; Photometrics, Tuscon, AZ) mounted onto a Zeiss upright fluorescence microscope equipped with a 40ϫ, 0.8 NA water-immersion objective. Membrane voltage was held at Ϫ65 mV to prevent any contribution from Ca 2ϩ influx via voltage-gated channels. Relative changes in [Ca 2ϩ ] i were quantified by calculating ⌬F/F 0 , where F 0 is the fluorescence intensity before stimulation (after subtracting background fluorescence), and ⌬F is the change in fluorescence during neuronal activity (corrected for bleaching). Pixels were binned in a 10 ϫ 10 array. Experiments were performed at 32°C.
Data analysis. Fluorescence intensity was measured over regions of interest (ROI) in the soma and the neurites. ROI were ϳ5 ϫ 5 m. In PC12 cells, ROI over the cell body and the growth cones were 80 -100 m apart. In hippocampal neurons, ROI were placed every 5-15 m from the soma to distal sections of large caliber dendrites. A 9-1 moving average filter was applied to PC12 cell traces. The onset of the signal was determined as the time point at which F/F 0 began to rise above 10% of the interval between F 0 and F max for the first time (see Fig. 4a , arrows). The flux rate was calculated as the slope of a line between the data point at which the onset of the signal was determined and the data point at which F/F 0 reached 90% of the interval between F 0 and F max . The self-ratio method was used because it is a measurement independent of factors such as dye concentration, excitation intensity, and detector efficiency. Statistical significance was tested using the unpaired Student's t test at p Ͻ 0.05.
Results

Asymmetric subcellular distribution of proteins of the InsP 3 signaling cascade in neuronally differentiated PC12 cells
To test whether the initiation site and release kinetics of intracellular Ca 2ϩ signals were determined by a nonuniform distribution of proteins involved in InsP 3 -mediated Ca 2ϩ release, we examined the localization of major components of the InsP 3 signaling pathway in NGF-differentiated PC12 cells. These elements were labeled using protein-specific primary antibodies and fluores- cently tagged secondary antibodies and were visualized by confocal microscopy ( Fig. 2a,b) . PLC␤ and the wortmannin-sensitive III␤ isoform of PI4K (PI4K␤) were balanced evenly between the soma and the neurite with no apparent concentration in either cell compartment (Fig. 2a) . The same results were obtained for the other PI4K subtypes (data not shown). In contrast, the distribution of PIPKI␥, the next step in InsP 3 synthesis, was specifically targeted to the growth cones and branching points of the neurites. Prominent protein clusters at the tip of and in the course of the processes of a cell were seen, whereas staining in the cell body was weak in comparison. The bottom panels in Figure 2 show a quantification of the fluorescence intensity along a typical neurite, plotted as a function of the distance from proximal to distal sections of the cell. When PIP 2 levels were estimated by monitoring the location of a fusion protein containing the pleckstrin homology domain of PLC␦1 linked to cyan fluorescent protein CFP-PLC␦1(PH) (Johenning et al., 2004) , the distribution was found to follow the localization of PIPKI␥ (Fig. 2a) . We next investigated the distribution of the chromogranin proteins, modulators of receptor activity from the luminal side of the Ca 2ϩ channel (Thrower et al., 2002 (Thrower et al., , 2003 . Both CGA and CGB were highly concentrated in the neurites, especially at the growth cones, and staining in the cell body was weak (Fig. 2a) . Quantification of the fluorescence intensity along a typical neurite is shown below the immunofluorescence panel. Together with the results for PIPKI␥, these findings suggested that protein domains are in the position to enhance Ca 2ϩ signals via two distinct "ON mechanisms": (1) increased PIP 2 levels that would augment stimulus-induced InsP 3 production and (2) increased sensitivity of the InsP 3 R by chromogranin binding to the luminal side of the receptor, which would allow faster activation of the InsP 3 R. To confirm that differences in the distribution of Ca 2ϩ stores did not account for the greater efficiency of neurites in generating Ca 2ϩ transients, we labeled live cells with ERTracker dye. The ER extended throughout the entire cell and was concentrated to the same extent in the soma and growth cones (Fig. 2a) .
In support of our hypothesis that ON mechanisms enhance localized Ca 2ϩ signaling, we found no such striking distribution for the various "OFF mechanisms." Immunoreactivity for the Ca 2ϩ -ATPases in the plasma membrane (PMCA1) and sarco-endoplasmic reticulum (SERCA2) that extrude Ca 2ϩ from the cytoplasm was detected in the entire cell with an evenly balanced ratio between the cell body and its processes (Fig. 2b, (Fig. 2b) . The Ca 2ϩ buffer parvalbumin was more concentrated in the soma and only showed weak staining in the neurites (Fig. 2b) , thus displaying a pattern opposite to the elements associated with activation of intracellular Ca 2ϩ signals (Fig. 2a) .
Distinct subcellular distribution of InsP 3 signaling proteins in cultured hippocampal neurons
To determine whether asymmetric protein localization was a general principle used by other cell types, we examined the spatial distribution of components of the InsP 3 pathway in cultured hippocampal neurons (Fig. 3a,b) . Fluorescence intensity was quantified as described for Figure 2 . In these cultures the majority of the neurons had the size and shape expected of pyramidal cells. The analysis of mGluRs focused on types 1 and 5, because these subtypes are known to be components of the InsP 3 R signaling pathway by their coupling with PLC␤ via the G-protein G q and they represent the predominant isoforms involved in Ca 2ϩ signaling in neurons from the hippocampus and many other regions of the brain (Nakamura et al., 2000) . mGluR1 immunoreactivity was detected in the entire neuron, extending from the cell body to distal dendrites. In contrast, mGluR5 was confined to the soma, and only faint staining was observed in proximal dendrites (Fig.  3a) . This is similar to the localization of mAChRs in PC12 cells (Johenning et al., 2002) . The distribution of PLC␤ was essentially uniform. PI4K␤ was predominately localized in the cell body and dendrites coming off the cell body up to the bifurcation. More distal dendrites appeared weaker. We observed high concentrations of PIPKI␥ in perinuclear regions of the soma. Lower levels were detected in distal parts of the neuron (Fig. 3a) . InsP 3 R1 was most prominent in the cell body and in the shafts of large-caliber dendrites. The absence of InsP 3 R2 in hippocampal neurons (Sharp et al., 1999 ) was confirmed; however, substantial InsP 3 R2-specific immunoreactivity was associated with glial cells (data not shown). We found small quantities of InsP 3 R3 restricted to the soma. Distal dendrites were not labeled (Fig. 3a) . RyR1 was mainly localized in the soma, although some protein extended into more distal parts of the cell, mostly large caliber dendrites. Figure 2 . Activators of Ca 2ϩ signaling are depicted in green. Nuclei are in blue. Cells with purely nuclear staining are glia. mGluR1 was detected throughout the neuron, reaching from the soma to distal dendrites. mGluR5, in contrast, was localized predominately in the cell body; staining in the dendrites was weak and restricted to proximal sections. A differential interference contrast (DIC) image is shown on the right. PLC␤ distribution was essentially uniform. Immunoreactivity for PI4K␤ was found to be ubiquitous with an emphasis on the soma and the apical dendrite up to the bifurcation. Staining for PIPKI␥ was especially strong in perinuclear regions of the cell body and in the proximal primary dendrite. InsP 3 R1 was readily detected in the soma and the shaft of large-caliber dendrites. Although there was no evidence for InsP 3 R2 (data not shown), small levels of InsP 3 R3 were localized in the cell body. RyR1 staining was strong in the soma and extended into large dendrites. Little RyR2 was found in central compartments of the neuron. RyR3 was distributed throughout the cell; high levels were observed in the soma and dendritic spines. CGB was localized exquisitely in the soma and shafts of large proximal dendrites with no staining in distal parts of the cell. Scale bar, 20 m. b, Components inhibiting the InsP 3 pathway are more uniformly distributed. Proteins were visualized as in Figure 3a . Inhibitors are depicted in red. Even distribution lacking apparent concentration was found for PMCA1, SERCA2, and parvalbumin. Scale bar, 20 m.
Weak staining for RyR2 was found in central compartments of the neuron. RyR3 was distributed throughout the neuron with particularly strong staining in the cell body and dendritic spines (Fig. 3a) . Finally, CGB was exquisitely targeted to the soma and invaded only the proximal dendrites. No labeling in distal cell compartments was observed (Fig. 3a) .
The distribution of proteins reducing intracellular Ca 2ϩ levels was similar to that found in NGF-treated PC12 cells (compare Figs. 2b, 3b) . The Ca 2ϩ pumps PMCA1 and SERCA2 were readily detected throughout the entire neuron lacking obvious subcellular localizations (Fig. 3b) . Parvalbumin, a Ca 2ϩ buffer abundant in many neuronal cell types (Baimbridge et al., 1992) , was localized to the same extent in the cell body and the dendrites (Fig. 3b) . Together, the soma and proximal dendrites of hippocampal neurons in culture appear to concentrate many proteins able to trigger and sustain intracellular Ca 2ϩ transients, whereas inhibiting elements such as pumps and buffers were evenly balanced. When NGF-differentiated PC12 cells were stimulated by application of the mAChR agonist carbachol, a rise in [Ca 2ϩ ] i was observed in both the soma and the growth cones (Fig. 4a, top  left) . The Ca 2ϩ signal clearly initiated in the neurite followed by the cell body after a delay (see expanded time scale in Fig. 4a,  bottom left) . Averaging over all cells revealed a latency of 0.78 Ϯ 0.28 s between the onset of the Ca 2ϩ transient in the growth cones and the soma (Fig. 4b, left) . The signal was of greater amplitude and reached peak values faster in the neurite (Fig. 4b, right) . This lower threshold for activation in the growth cones was observed in 83% of cells analyzed (n ϭ 12).
Cultured hippocampal neurons were stimulated with the selective group I mGluR agonist DHPG (50 M). In an effort to isolate Ca 2ϩ signals attributable to internal release from influx of Ca 2ϩ through voltage-gated Ca 2ϩ channels, neurons with pyramidal-like morphology were held in voltage-clamp mode at resting or hyperpolarizing levels. To suppress network activity, we included the ionotropic glutamate antagonist DNQX (10 M) in the perfusion media. Consistent with the distributions of CGB and PIPKI␥, we only observed the onset of internal Ca 2ϩ release in the soma or primary dendrite just proximal to the soma. Overall, the apparent site of initiation could be associated either with the soma (38%) or the proximal primary dendrite (62%). Release that began in the soma propagated distally toward the dendrite (Fig. 5a ), whereas release initiating in the proximal dendrites propagated bidirectionally (Fig. 5c) .
By plotting the latency between the onset of the signal in the soma and in the distal dendrites as a function of increasing distance (Fig. 5b,d, left) , it could be seen that the propagation velocity was not uniform. The Ca 2ϩ signal spread faster near the site of initiation and slowed as it traveled out. There also was a gradual decrease in amplitude and rate of rise as the wave spread along the main dendritic trunk into distal branches (Fig. 5b,d, right) . Ca 2ϩ transients near the soma were characterized by a greater magnitude and high flux rate; signals in the distal branches were low in amplitude and rate of rise. A comparison of the kinetics of the three analyzed parameters for a single neuron showed a high degree of congruency. In all cells, the signal recorded at the initiation site was always the greatest in amplitude and rate of rise compared with the transients measured further away.
Functional chromogranin-InsP 3 R coupling contributes to shaping Ca 2؉ transients Chromogranin proteins are predicted to be an enhancing element of InsP 3 -mediated Ca 2ϩ release (Thrower et al., 2002 (Thrower et al., , 2003 . To test this prediction, the chromogranin-InsP 3 R interaction was inhibited by expressing a CGB polypeptide fragment that has been shown to disrupt their functional coupling (Choe et al., 2004) . PC12 cells were transfected either with the chromogranin fragment or with a scrambled peptide as control, or were not transfected. The distribution of the InsP 3 R was unchanged by this treatment. When stimulated, cells transfected with the scrambled peptide displayed increases in intracellular Ca 2ϩ in the growth cone first with the signal appearing in the soma after a delay of 2.0 s (Fig. 6a) . This order was reversed in cells expressing the CGB fragment: Ca 2ϩ levels rose first in the soma followed by the neurite after 2.0 s (Fig. 6b) . Overall, there was no difference in the signal delay between untransfected cells and cells transfected with the scrambled peptide (1.78 Ϯ 0.54 vs 1.83 Ϯ 0.33 s). The CGB fragment, however, significantly altered the site of initiation in favor of the soma (Ϫ0.83 Ϯ 0.59 s) (Fig. 6c) . These data provide a strong argument for the involvement of chromogranins in shaping intracellular Ca 2ϩ transients. Unexpectedly, when the chromogranin-InsP 3 R coupling was inhibited, the magnitude and rate of rise of the Ca 2ϩ signal were depressed to a greater extent in the cell body. Again, no difference was observed between controls and cells transfected with the scrambled peptide (Fig. 6d) . The average values for the neurites were as follows (percentage of controls): 102 Ϯ 11 and 106 Ϯ 26 for amplitude and flux rate with the scrambled peptide, respectively; 63 Ϯ 12 and 35 Ϯ 13 for amplitude and flux rate with the CGB fragment, respectively. The average values for the soma were as follows (percentage of controls): 91 Ϯ 14 and 91 Ϯ 30 for amplitude and flux rate with the scrambled peptide, respectively; 31 Ϯ 10 and 14 Ϯ 7 for amplitude and flux rate with the CGB fragment, respectively.
Reduction of PIP 2 levels alters the site of signal initiation
The asymmetric distribution of PIPKI␥ lead to the suggestion that higher PIP 2 levels in "hot spots" could play a role in explaining the distinct spatiotemporal pattern of Ca 2ϩ signals. We therefore inhibited PIPKI␥ function by depriving the enzyme of its substrate PIP by treating NGF-differentiated PC12 cells with wortmannin, an inhibitor of type III PI4K (Downing et al., 1996; Meyers and Cantley, 1997) . Cells were preincubated for 20 min in growth medium supplemented with 10 M wortmannin, a dose sufficient to block all PI4KIII activity and decrease PIP levels (Sorensen et al., 1998) . Treated cells were then stimulated with carbachol, and Ca 2ϩ signals were recorded. In contrast to untreated cells, the rise in [Ca 2ϩ ] i in a representative cell pretreated with wortmannin clearly initiated in the soma (Fig. 7a) . Both the amplitude and flux rate were greatly depressed in the growth cone, whereas the soma seemed less affected. The average temporal delay for wortman- nin was Ϫ1.87 Ϯ 0.52 s, indicating that the rise in [Ca 2ϩ ] i in the cell body preceded the growth cones by almost 2 s (Fig. 7e) . The latency between the onset of the signal in the neurite and the soma was 1.31 Ϯ 0.29 s for control cells. Thus, incubation with wortmannin reversed the order in which the signal initiated in the two cell compartments. This result strongly implicates PIPKI␥ as an important component in determining the site of signal initiation.
Wortmannin not only affects PI4K but also PI3K and myosin light chain kinase (Nakanishi et al., 1995) . Therefore, we needed to show that the shift in the site of signal origin was achieved by inhibition of PI4K and not by another kinase. First, PC12 cells were incubated for 20 min with increasing doses of wortmannin (from 1 nM to 50 M), and the carbachol-induced changes in [Ca 2ϩ ] i were recorded ( Fig. 7b-d) . Wortmannin concentrations in the nanomolar range are sufficient to potently inhibit PI3K (Sorensen et al., 1998) . However, no effect on any of the parameters analyzed was observed below 1 M (Table  1) . Between 1 and 50 M, the ability of the growth cone to generate early Ca 2ϩ responses was markedly reduced, indicated by the gradual decrease in measured latency. At 50 M, the neurite trailed behind the soma by 2.6 s (Fig. 7b) . Very similar kinetics were observed for the magnitude.
The dose-response curve shows that under control conditions the growth cones released twofold more Ca 2ϩ from their intracellular stores compared with the cell body and that this proportion changed with increasing wortmannin doses (Fig.  7c) . The ratio of the magnitude obtained under control conditions and with 50 M wortmannin shows that there was a decrease by a factor of 6 in the cell body, and the amplitude in the neurite declined by a factor of 48 (Fig. 7c, inset) . Consistent with the reduction in latency to rise and magnitude, the flux rate of the Ca 2ϩ signal decreased in the same wortmannin range (Fig. 7d) . This parameter reflects InsP 3 R open probability during the main activation phase (Ogden and Capiod, 1997) . Again, a decrease was observed only at wortmannin concentrations Ͼ1 M. The ratio of reduction, as calculated for the amplitude, was 12 for the growth cones and 5 for the soma (Fig. 7d, inset) .
The IC 50 value for the effect of wortmannin on the parameters analyzed was ϳ7.5 M. This is three orders of magnitude higher than the concentrations needed to inhibit PI3K (Sorensen et al., 1998 ). To further demonstrate that the effect achieved with wortmannin can be ex- plained by PI4K inhibition, we preincubated PC12 cells for 20 min with 100 M LY294002, a selective inhibitor of PI3K (Vlahos et al., 1994; Suh and Hille, 2002) and recorded the carbacholinduced Ca 2ϩ signals. There was no effect on the latency, amplitude, or rate of rise of [Ca 2ϩ ] i ( Fig. 7e; Tables 1, 2) . Furthermore, depleting the cell of PI, which is the substrate of PI4K, also would be expected to affect the spatiotemporal pattern of Ca 2ϩ transients. PC12 cells were pretreated for 10 min with 40 M R59022, a DAG kinase inhibitor. This interrupts the lipid cycle after DAG, and PI cannot be replenished from phosphatidic acid (Ford et al., 2003) (Fig. 1) . As expected, all three parameters were altered as seen for wortmannin ( Fig. 7e; Tables 1, 2) . These results support the prediction that reduction of PIP 2 levels by (indirect) PIPKI␥ inhibition is the mechanism for the change in spatiotemporal Ca 2ϩ signaling (Fig. 7a) and that asymmetric levels of PIP 2 within a cell play a role in shaping the pattern of Ca 2ϩ signals.
Discussion
The experiments described here demonstrate that neuronal cells can modulate the kinetics and initiation sites of Ca 2ϩ transients by differentially distributing proteins involved in the InsP 3 signaling cascade. Our observations suggest that proteins that increase InsP 3 R open probability by increasing PIP 2 production (PIPKI␥) and receptor sensitization (chromogranin proteins) are purposefully targeted to specific sections of the neuron. These protein elements become the building blocks of specialized domains enabling the cell to generate early, high-amplitude, and fast Ca 2ϩ signals in these compartments. In the neuron types investigated here, the location of the highest density of PIPKI␥ and CGB predicted the site of Ca 2ϩ signal initiation. Previously, the localization of Ca 2ϩ release channels in PC12 cells was examined (Johenning et al., 2002) . The lowthreshold InsP 3 sensor InsP 3 R1 was found throughout the entire cell, whereas the high-threshold sensor InsP 3 R3 was targeted predominately to the soma. Therefore, the distribution of InsP 3 Rs alone cannot explain the differences in Ca 2ϩ signaling in PC12 cells unless heterotetrameric InsP 3 R (combinations of type 1 and 3 InsP 3 R) are formed in the cell body with a significantly lower affinity for InsP 3 . PLC␤-coupled receptors in the plasma membrane for the muscarinic agonist carbachol, mAChRs, were found mainly in the soma and only in smaller clusters along the neurite (Johenning et al., 2002) , again suggesting that the localization of this protein cannot account for the signaling differences observed. In contrast, the distribution of PIPKI␥ and CGB in PC12 cells described in this study is an explanation.
In hippocampal neurons, many elements enhancing InsP 3 -mediated Ca 2ϩ signaling were localized predominately in the soma or proximal apical dendrite, most notably PIPKI␥ and CGB, whereas Ca 2ϩ buffers and pumps were distributed uniformly (Fig. 3a,b) . As predicted by our model and consistent with previous reports (Pozzo-Miller et al., 1996; Yeckel et al., 1999; Kapur et al., 2001; Larkum et al., 2003) , the Ca 2ϩ signal began in the proximal dendrites or soma (Fig. 5a,c) , regions that also exhibited the highest amplitude and flux rate for the Ca 2ϩ transients (Fig. 5b,d) . Moreover, the Ca 2ϩ wave spread faster in central compartments where high concentrations of proteins activating the InsP 3 pathway were located and slowed in the periphery where levels of these proteins were diminished (Fig. 5b,d) . Together, these results support the concept that protein domains enhance intracellular Ca 2ϩ signaling and that conclusions generated from experiments with neuronally differentiated PC12 cells can be adapted to other types of neurons.
The striking effect on the initiation site and kinetics of the Ca 2ϩ transient achieved by blocking PI4KIII and, indirectly, PIPKI␥ with wortmannin ( Fig. 7) clearly implies a role for PIP and PIP 2 as immediate InsP 3 precursors in shaping spatiotemporal Ca 2ϩ signaling patterns. The expectation was that the decrease in phospholipid levels after incubation with wortmannin would affect the soma and growth cones to the same extent, because PI4K distribution was uniform (Fig. 2a) . However, the relative decrease of the measured parameters for Ca 2ϩ signals as represented by the ratio of the control values to the values obtained with full wortmannin inhibition was not the same for the soma and the growth cone (Fig. 7c,d , insets; Table 1 ). This meant that factors in addition to phospholipid levels alone needed to be considered. The chromogranin proteins were likely candidates because of their asymmetric distribution similar to PIPKI␥ (Fig.  2a) . By disrupting the interaction between CGB and the InsP 3 R with a CGB polypeptide fragment (Choe et al., 2004) , the site of initiation was shifted to the soma (Fig. 6b,c) . This result shows that the functional channel complex consisting of the InsP 3 R and CGB is crucial for shaping intracellular Ca 2ϩ signals. The observation that the CGB fragment altered the site of initiation in favor of the cell body but reduced the amplitude and flux rate to a greater extent in this compartment was unexpected (Fig. 6d) . The possibility that the CGB fragment was localized to the soma was ruled out because examination of myc-tagged CGB fragment confirmed that the polypeptide is expressed to the same degree in the cell body and the neurites (data not shown). Another possibility is that not all CGB-InsP 3 R interaction is disrupted in the growth cones because of the abundance of native CGB, further emphasizing the importance of CGB for local Ca 2ϩ signaling in the neurites as the initiation site is shifted despite functional complexes remaining.
With the components of the Ca 2ϩ signaling tool kit identified here, it is possible to propose a model to explain the diverse spatiotemporal patterns of InsP 3 -mediated neuronal Ca 2ϩ signals. When PIP is abundant in the entire cell, the first rate-limiting step in InsP 3 synthesis is PIPKI␥ activity. PIP 2 levels are considerably higher in the neurite as a consequence of the higher density of PIPKI␥ in the growth cones as described here (Fig. 2a) and in other systems in which the synapses of primary neurons are rich in PIPKI␥ and PIP 2 (Micheva et al., 2001; Wenk et al., 2001) . The large pool of PIP 2 substrate for PLC␤ is vital for compensating for the asymmetric localization of mAChRs, the second major factor determining InsP 3 generation. Given the low density of receptors in the growth cones, only small amounts of PLC␤ can be activated after stimulation with muscarinic agonists. Consequently, PIP 2 cannot be efficiently metabolized in the neurite to yield high InsP 3 levels. Previous experiments have already excluded the possibility of increased InsP 3 production in the neurite as the mechanism underlying the observed temporal delay (Johenning et al., 2002) . The InsP 3 levels in the neurite still suffice to generate signals of higher magnitude and flux rate compared with the soma, because the InsP 3 Rs in the growth cones are more sensitive to their ligand and a better surface/volume ratio favors the neurite. Higher sensitivity is conferred by multiple factors, including the location of higher-affinity InsP 3 R1s and high chromogranin levels (Fig. 2a) .
Inhibiting PI4KIII with wortmannin drastically reduces PIP levels uniformly throughout the cell (Sorensen et al., 1998) , and the PIP concentration becomes rate limiting in InsP 3 synthesis. The nonuniform distribution of PIPK is of no further consequence. The low density of mAChRs in the neurite is no longer sufficient to generate adequate InsP 3 concentrations in the neurite, because the growth cone is dependent on an abundant supply of PIP 2 to ensure that activation of PLC␤ to cleave PIP 2 is efficient. This can be seen as the disproportionate decline in amplitude and flux rate of [Ca 2ϩ ] i in the neurite in relation to the soma ( Fig. 7c,d ; Table 1 ). Under these conditions, high CGB levels are insufficient to adequately sensitize the InsP 3 R, and the synergism between receptor activation by elevated InsP 3 precursors and high chromogranin concentrations breaks down. Support for the notion that synergistic receptor activation in the neurite is crucial for efficient intracellular Ca 2ϩ signaling comes from the observation that early interference in the InsP 3 pathway In three sets of experiments, cells were incubated with the indicated concentrations of (1) The delay between the onset of the signal in the neurite and the soma is displayed as ⌬t (soma Ϫ neurite) . In three sets of experiments, cells were incubated with the indicated concentrations of (1) with wortmannin affects the magnitude and rate of rise of the Ca 2ϩ transient to a greater degree than late inhibition with the CGB fragment (Table 1) .
Additional variables are certain to influence InsP 3 -mediated signaling. Phosphorylation of the InsP 3 R in the neurite increasing sensitivity for its ligand (Tang et al., 2003) may play a role as well as differing densities of InsP 3 R1 and InsP 3 R3 throughout the cell (Shuai and Jung, 2003) . Although RyRs do not seem to influence signal initiation, the higher concentration of RyRs in the soma could compensate for the high-threshold InsP 3 R3, facilitating Ca 2ϩ release (Johenning et al., 2002) . Higher-ordered structures that link together receptors, G-proteins, PLCs, and InsP 3 Rs by scaffolding proteins such as Vesl/Homer guarantee specificity of signal transduction and prevent unwanted cross talk between different signaling pathways (Delmas et al., 2002) . Overall, the interactions among the components of the Ca 2ϩ signaling cascade in the cells described here indicate how a set of parameters can be manipulated to achieve cellspecific responses.
One purpose for Ca 2ϩ signaling domains in growth cones is particularly intriguing. Ca 2ϩ , among other second messengers, is known to regulate neurite outgrowth and guidance of axons by extracellular factors (Hong et al., 2000; Nishiyama et al., 2003) . The Ca 2ϩ elevation in growth cones necessary to modulate attraction and repulsion is essentially attributed to influx from the extracellular space through plasma membrane channels and efflux from RyRs. Our data point to the possibility that, in addition, Ca 2ϩ release from InsP 3 -sensitive internal stores may be specifically boosted by the protein domains found in the growth cones to contribute to axon guiding (Takei et al., 1998) .
In conclusion, we provide here experimental data to elucidate the mechanism underlying distinct spatiotemporal Ca 2ϩ signaling patterns in neuronal cells. We have identified the growth cones of neuron-like pheochromocytoma cells as special cell compartments equipped with unique protein machinery to efficiently generate Ca 2ϩ transients. By favoring the Ca 2ϩ "source" over the "sink," these cells establish protein domains to enhance InsP 3 -mediated Ca 2ϩ signaling, ensuring speed and spatial localization of Ca 2ϩ release. Furthermore, we demonstrated that this system is in use in hippocampal neurons, suggesting a general principle in the cell biology of neurons and possibly nonexcitable cells.
